Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2018 / Cilt: 52 - Sayı: 4

Evaluation of clinical course, histopathological and treatment characteristics of patients with Kaposi's sarcoma

Kaposi sarkomu tanısı alan hastaların klinik seyir, histopatolojik ve tedavi özelliklerinin değerlendirilmesi

Pages
131–136
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Screening and follow-up of the secondary malignancies that mayaccompany KS should be carried out with caution.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Kaposi’s sarcoma (KS) is an angioproliferative disease of vascular endothelium associated with human herpes virus-8(HHV-8).
📊
Key Findings & Data:The purpose of this study was to evaluate the clinical course, histopathological and treatment characteristics in patients with KS.Materials and Methods: A retrospective study was conducted on 77 patients with KS who attended the Dermatology Outpatient Clinic inthe İstanbul Training and Research Hospital between April 2008 and December 2016.
💡
Conclusion & Impact:Screening and follow-up of the secondary malignancies that mayaccompany KS should be carried out with caution.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Background and Design: Kaposi’s sarcoma (KS) is an angioproliferative disease of vascular endothelium associated with human herpes virus-8(HHV-8). The purpose of this study was to evaluate the clinical course, histopathological and treatment characteristics in patients with KS.Materials and Methods: A retrospective study was conducted on 77 patients with KS who attended the Dermatology Outpatient Clinic inthe İstanbul Training and Research Hospital between April 2008 and December 2016. The clinical course, histopathological and treatmentcharacteristics were evaluated from the hospital records.Results: The mean age of the patients was 67.4±13.8 years. 67.5% of patients were male and 32.5% were female. Five patients (6.5%) hadoral mucosal involvement. Human immunodeficiency virus positivity was detected in 4 patients (5.2%). HHV-8, CD-31 and CD-34 positivity weredetected in 94.0%, 98.0% and 84.2% of patients, respectively. Three patients (3.9%) had secondary malignancy (1 patient had lymphoma, 1had thyroid carcinoma and 1 had bladder carcinoma). The most commonly used treatments were cryotherapy (26.3%) as monotherapy, andexcision and cryotherapy (14.8%) as combination therapy.Conclusion: Clinical and histopathological features are important in establishing the diagnosis of KS. In our study, the rate of unresponsivenessto treatment observed in follow-up was low and progression was rare. Screening and follow-up of the secondary malignancies that mayaccompany KS should be carried out with caution.

Özet

Amaç: Kaposi sarkomu (KS) vasküler endotelin human herpes virüs-8 (HHV-8) ile ilişkili etiyopatogenezi tam olarak bilinmeyen anjiyoproliferatif bir hastalığıdır. Ülkemizde dermatoloji kliniklerinden KS ile ilgili sınırlı sayıda çalışma bulunmaktadır. Bu çalışma ile İstanbul ilinde KS’nin klinik seyir, histopatoloji ve tedavi özelliklerinin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Nisan 2008-Aralık 2016 tarihleri arasında dermatoloji polikliniğine başvurmuş ve KS tanısı almış olan 77 hastanın klinik seyri, histopatoloji ve tedavi özellikleri hastane otomasyon sistemindeki kayıtlardan retrospektif olarak incelenmiştir. Bulgular: Yetmiş yedi hastanın 25'i (%32,5) kadın, 52’si (%67,5) erkek olup, yaş ortalamaları 67,4±13,8 idi. Beş hastada (%6,5) oral mukozal tutulum bulunmakta idi. İnsan immün yetmezlik virüsü pozitifliği hastaların 4’ünde (%5,2) saptanmış olup, bu hastalarda mukozal ve visseral tutulum yoktu. İmmünohistokimyasal olarak değerlendirilen hastalarda HHV-8, CD-31 ve CD-34 pozitifliği sırası ile %94,0, %98,0 ve %84,2 saptandı. Çalışmamızda hastaların 3’ünde (%3,9) sekonder malignite (bir hastada lenfoma, bir hastada tiroid karsinomu ve bir hastada mesane karsinomu) mevcuttu. En sık kullanılan tedavi yöntemi monoterapi olarak kriyoterapi (%20,8), kombine tedavi olarak ise eksizyon ve kriyoterapi (%11,7) idi. Sonuç: KS tanısında klinik ve histopatolojik özellikler önemlidir. Çalışmamızda KS hastalarının takibinde tedaviye yanıtsızlık oranı düşük ve progresyon nadir olarak görülmektedir. KS’ye eşlik edebilecek sekonder malignitelerin tarama ve takibi dikkatli yapılmalıdır.

🔖

Cite This Article

GÜREL, M. S., LEBLEBİCİ, C., AKSU, A. E. K., KARAALİ, M. G., POLAT, A. K. (2022). Evaluation of clinical course, histopathological and treatment characteristics of patients with Kaposi's sarcoma. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 52 - Sayı: 4, 131–136. https://ajindex.com/articles/621685

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. North PE, Kincannon J: Vascular Neoplasms and Neoplastic-like Proliferations. Dermatology. Ed. Bolognia JL, Jorizzo JL, Schaffer JV. 3rd ed. St. Louis, Mosby Elsevier, 2012:1932-5.
  2. Buonaguro FM, Tornesello ML, Buonaguro L, et al: Kaposi’s sarcoma: aetiopathogenesis, histology and clinical features. J Eur Acad Dermatol Venereol 2003;17:138-54.
  3. Wu XJ, Pu XM, Kang XJ, et al: One hundred and five Kaposi sarcoma patients: a clinical study in Xinjiang, Northwest of China. J Eur Acad Dermatol Venereol 2014;28:1545-52.
  4. Schneider JW, Dittmer DP: Diagnosis and treatment of Kaposi sarcoma. Am J Clin Dermatol 2017;18:529-39.
  5. Akinde O, Obadofin O, Adeyemo T, et al: Kaposi sarcoma among HIV infected patients in Lagos University Teaching Hospital, Nigeria: A 14-Year retrospective clinicopathological study. J Skin Cancer 2016;2016:9368023. Guttman-Yassky E, Bar-Chana M, Yukelson A, et al: Epidemiology of classic Kaposi’s sarcoma in the Israeli Jewish population between 1960 and 1998. Br J Cancer 2003;89:1657-60.
  6. Stiller CA, Trama A, Brewster DH, et al: Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project. Cancer Epidemiol 2014;38:670-8.
  7. Demirel BG, Koca R, Solak Tekin N, ve ark: Klasik Kaposi sarkomu: Yetmiş dört hastanın klinik, demografik özellikleri ve tedavi sonuçlarının değerlendirilmesi. Turkderm 2016;50:136-40.
  8. Su Ö, Onsun N, Arda H, ve ark: Klasik Kaposi sarkomlu olgularda klinik özellikler, insan herpesvirüs-8’in varlığı ve tedavi sonuçları. Turkderm 2008;42:122-6.
  9. Doğan Gün B, Bahadır B, Ekem TE, ve ark: Klasik Kaposi sarkomu: klinik ve immünohistokimyasal özellikler. Turkiye Klinikleri J Dermatol 2007;17:21-5.
  10. Mohanna S, Ferrufino JC, Sanchez J, Bravo F, Gotuzzo E: Epidemiological and clinical characteristics of classic Kaposi’s sarcoma in Peru. J Am Acad Dermatol 2005;53:435-41.
  11. Weissmann A, Linn S, Weltfriend S, Friedman-Birbaum R: Epidemiological study of classic Kaposi’s sarcoma: a retrospective review of 125 cases from Northern Israel. J Eur Acad Dermatol Venereol 2000;14:91-5. Piette WW: The incidence of second malignancies in subsets of Kaposi’s sarcoma. J Am Acad Dermatol 1987;16:855-61.
  12. Safai B, Mike V, Giraldo G, Beth E, Good RA: Association of Kaposi’s sarcoma with second primary malignancies. Cancer 1980;45:1472-9. Paradžik M, Bučević-Popović V, Šitum M, et al: Association of Kaposi’s sarcoma-associated herpesvirus (KSHV) with bladder cancer in Croatian patients. Tumour Biol 2014;35:567-72.
  13. Lee S, Jang J, Jeon